GUFICBIO Share Price Discussion

Gufic BioSciences Ltd.
Sector: Pharmaceuticals and health care

GUFICBIO Share Price *

62.25 -2.05 (-3.19%)

* (quote may be delayed)

Find answers to all your questions on live GUFICBIO message board: Is GUFICBIO buy or sell? Should I buy GUFICBIO shares? Why are GUFICBIO shares falling? Should I invest in GUFICBIO stock?

GUFICBIO Discussion Forum

NewsBot @newsbot

GUFICBIO

•

Oct 4 2:38 AM

Miracle aging treatment Botox set to face fight from this little-known Indian firm
BSE-listed Gulfic Biosciences has received approvals to manufacture and sell Botulinum toxin, better known by popular brand name Botox.

Moneycontrol

https://www.moneycontrol.com/news/business/companies/mira...

GUFICBIO - Share Price - Fundamentals
Market Capitalization 837.86
Enterprise Value 910.45
Price to Earnings 52.3
Price to Book Value 15.66
Return on Capital Employed 0.29
Return on Equity 0.3
Face Value 1
Dividend Yield NA
GUFICBIO Share Price - Technicals
GUFICBIO - 52 Week High ₹99.1
GUFICBIO - 52 Week Low ₹51.05
GUFICBIO Share Price - Historical (₹)
Date Open High Low Close
Dec 6 64.3 64.9 62.05 62.45
Dec 5 65.45 66.4 64.05 64.3
Dec 4 67.85 67.85 64.4 65.4
Dec 3 69.3 70.8 67.15 67.7
Dec 2 69.45 70.2 68 68.3
GUFICBIO Share Price - Daily Moving Averages (DMA)
20 Day Moving Average ₹67.32
30 Day Moving Average ₹68.38
50 Day Moving Average ₹69.35
100 Day Moving Average ₹66.32
200 Day Moving Average ₹71.68
GUFICBIO - Profit And Loss
CONSOLIDATED Mar-18 Mar-17 % Change
Revenue 300.96 249.27 0.21
Operating Profit 38.16 26.97 0.41
Profit Before Tax 29.54 18.02 0.64
Net Income 16.02 11.41 0.4
GUFICBIO - Balance Sheet
CONSOLIDATED Mar-18 Mar-17 % Change
Shareholder's Funds 53.52 44.91 0.19
Total Liabilities 182.55 134.41 0.36
Total Assets 236.07 179.32 0.32
GUFICBIO - Cash Flow
CONSOLIDATED Mar-18 Mar-17 % Change
Cash from Operating Activity -4.85 -4.4 0.1
Cash from Investing Activity -8.84 -3.32 1.66
Cash from Financing Activity 14.49 7.09 1.04
Net Cash Flow 0.8 -0.63 -2.27
GUFICBIO - Ratios
CONSOLIDATED Mar-18 Mar-17
Return on Assets 0.07 0.06
Return on Equity 0.3 0.25
Return on Capital Employed 0.29 0.24
GUFICBIO - 3 year Growth
3 Year CAGR Growth in Revenue 0.99
3 Year CAGR Growth in Operating Profit 1.67
3 Year CAGR Growth in EBIDTA 1.88
3 Year CAGR Growth in Net Income 2.85
3 Yr CAGR Growth - Diluted EPS 2.83
GUFICBIO - 5 year Growth
5 Year CAGR Growth in Revenue 2.01
5 Year CAGR Growth in Operating Profit 2.55
5 Year CAGR Growth in EBIDTA 2.84
5 Year CAGR Growth in Net Income 3.81
3 Yr CAGR Growth - Diluted EPS 3.81
GUFICBIO - Recent News
NewsBot
Oct 4 2:38 AM
Miracle aging treatment Botox set to face fight from this little-known Indian firm
Moneycontrol
GUFICBIO - Related Communities
WANBURY
Wanbury Ltd. Sector: Pharmaceuticals ...
PIRPHYTO
Piramal Phytocare Ltd. Sector: Pharma...
PARABDRUGS
Parabolic Drugs Ltd. Sector: Pharmace...
ORCHIDPHAR
Orchid Pharma Ltd. Sector: Pharmaceut...
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Lt...
WOCKPHARMA
Wockhardt Ltd. Sector: Pharmaceutical...
VIVIMEDLAB
Vivimed Labs Ltd. Sector: Pharmaceuti...
VENUSREM
Venus Remedies Ltd. Sector: Pharmaceu...
UNICHEMLAB
Unichem Laboratories Ltd. Sector: Pha...
TTKHLTCARE
TTK Healthcare Ltd. Sector: Pharmaceu...

Market Capitalization	837.86
Enterprise Value	910.45
Price to Earnings	52.3
Price to Book Value	15.66
Return on Capital Employed	0.29
Return on Equity	0.3
Face Value	1
Dividend Yield	NA

GUFICBIO - 52 Week High	₹99.1
GUFICBIO - 52 Week Low	₹51.05

Date	Open	High	Low	Close
Dec 6	64.3	64.9	62.05	62.45
Dec 5	65.45	66.4	64.05	64.3
Dec 4	67.85	67.85	64.4	65.4
Dec 3	69.3	70.8	67.15	67.7
Dec 2	69.45	70.2	68	68.3

20 Day Moving Average	₹67.32
30 Day Moving Average	₹68.38
50 Day Moving Average	₹69.35
100 Day Moving Average	₹66.32
200 Day Moving Average	₹71.68

CONSOLIDATED	Mar-18	Mar-17	% Change
Revenue	300.96	249.27	0.21
Operating Profit	38.16	26.97	0.41
Profit Before Tax	29.54	18.02	0.64
Net Income	16.02	11.41	0.4

CONSOLIDATED	Mar-18	Mar-17	% Change
Shareholder's Funds	53.52	44.91	0.19
Total Liabilities	182.55	134.41	0.36
Total Assets	236.07	179.32	0.32

CONSOLIDATED	Mar-18	Mar-17	% Change
Cash from Operating Activity	-4.85	-4.4	0.1
Cash from Investing Activity	-8.84	-3.32	1.66
Cash from Financing Activity	14.49	7.09	1.04
Net Cash Flow	0.8	-0.63	-2.27

CONSOLIDATED	Mar-18	Mar-17
Return on Assets	0.07	0.06
Return on Equity	0.3	0.25
Return on Capital Employed	0.29	0.24

3 Year CAGR Growth in Revenue	0.99
3 Year CAGR Growth in Operating Profit	1.67
3 Year CAGR Growth in EBIDTA	1.88
3 Year CAGR Growth in Net Income	2.85
3 Yr CAGR Growth - Diluted EPS	2.83

5 Year CAGR Growth in Revenue	2.01
5 Year CAGR Growth in Operating Profit	2.55
5 Year CAGR Growth in EBIDTA	2.84
5 Year CAGR Growth in Net Income	3.81
3 Yr CAGR Growth - Diluted EPS	3.81

SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

FrontPage Apps

Help About Privacy Terms Disclaimers Refunds

GUFICBIO Share Price Discussion

GUFICBIO Discussion Forum

GUFICBIO - Share Price - Fundamentals

GUFICBIO Share Price - Technicals

GUFICBIO Share Price - Historical (₹)

GUFICBIO Share Price - Daily Moving Averages (DMA)

GUFICBIO - Profit And Loss

GUFICBIO - Balance Sheet

GUFICBIO - Cash Flow

GUFICBIO - Ratios

GUFICBIO - 3 year Growth

GUFICBIO - 5 year Growth

GUFICBIO - Recent News

GUFICBIO - Related Communities